Product Images Simvastatin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Simvastatin NDC 71610-622 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 20 mg - 71610 0622 15
Bottle Label 40 mg - 71610 0623 15
Aphena Pharma Solutions - TN - Aphena
Footnote for Table 3 - Footnote for Table 3
The text describes the results of a chemical assay that may be used to identify inhibitors of CYP3A4 enzymes such as ketoconazole and erythromycin. Simvastatin acid, a metabolite of simvastatin, is defined. The effects of grapefruit juice on the pharmacokinetics of simvastatin have been studied at different concentrations in two studies. Grapefruit juice was administered with simvastatin in varying doses over a period of 3 days.*
Figure 9 - simvastatin 10
table2 - simvastatin 2
This is a table listing the adverse reactions reported by patients treated with Simvastatin compared to a placebo. The table includes categories such as body as a whole, cardiovascular system disorders, digestive system disorders, endocrine disorders, musculoskeletal disorders, nervous system/psychiatric disorders, respiratory system disorders, skin/skin appendage disorders, and urogenital system disorders. Adverse reactions reported with Simvastatin include Edema/swelling, Atrial fibrillation, Constipation, and Eczema, among others.*
Structure - simvastatin 3
table 3 - simvastatin 4
table 4 - simvastatin 5
Figure 5 - simvastatin 6
This is a statistical report on major vascular events and major coronary events. The report compares the effects of taking Simvastatin versus a placebo in patients with or without certain cardiovascular conditions. The number of patients in each category is provided, as well as the incidence of events. The report includes risk ratios with confidence intervals.*
Figure 6 - simvastatin 7
Figure 7 - simvastatin 8
The text contains some random characters and does not provide any useful information. Therefore, the description would be "Not available".*
Figure 8 - simvastatin 9
table 1 - table1
This is a medical table listing drug interactions that increase the risk of myopathy or rhabdomyolysis with recommended prescribing suggestions and restrictions for various drugs, including strong CYP3A4 inhibitors, protease inhibitors, cyclosporine, and some cardiovascular medications. The table also includes a warning about combining simvastatin with certain medications and grapefruit juice and notes that niacin should not be taken with simvastatin for Chinese patients. The last line appears to be a scanning error and is not readable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.